The Olympic Therapeutics AG has started the ILO at the ILO Exchange in London. The ILO Exchange is currently the one and only exchange, where you can subscribe for an ILO and trade the Licences after the ILO.
Please see our ILO site at the exchange for further information:
The initial ILO will contain 6,000 units with an issue price for each ILO of EUR 2,000. The total volume is EUR 12,000,000.
Globally, over 300 million people are afflicted with a serious fungal infection and 25 milllion are at high risk of dying or losing their sight.
For years, we have been researching the treatment of complicated fungal diseases and have successfully started to develop appropriate drugs.
We invite you, to subscribe to our ILO and to back us in getting our first product finished, which fights lethal fungal diseases.
The launch of the ILO Exchange is in the final phase, according to management of the ILO Exchange. Olympic Therapeutics AG has already been included in the listing under the symbol OT-ILO:
Dear Madam or Sir,
Olympic Therapeutics AG is one of the currently most interesting medical start-ups to fight dangerous fungal diseases. To get the business plan financed, the company is on the way to be one of the first companies to offer an innovative ILO (Initial Licence Offering) at ILOCX.
What is an ILO?
Initial licence offerings, also known as ILOs are a revenue-based form of raising money for seed stage and startup stage firms. Different from equity crowdfunding in that the transaction is not considered an investment, but a licence sale, ILOs are available to companies in every country, sector and stage.
The ILO is a straightforward intellectual property and distribution rights licence that expires after an agreed period of time, or is exchanged for cash under a buy back or for equity dependent upon the offering.
The company needs to show it has a product, technology or service which can be explosive in a tech and social market. This should be supported by market stats to show the potential for the product and financials/forecasts which demonstrate that the more ILO holders, the more value is created in the company.
Learn more about ILOs